Literature DB >> 9380367

Comparison of measures of visual acuity in infants: Teller acuity cards and sweep visual evoked potentials.

P M Riddell1, B Ladenheim, J Mast, T Catalano, R Nobile, L Hainline.   

Abstract

PURPOSE: This study compares the development of acuity in the same infants during one testing session using Teller acuity cards (TAC) and sweep visual evoked potentials (sVEP). We asked whether different testing methods in two centers would produce different developmental time courses.
METHODS: Forty-eight infants were tested in two centers. The standard procedure for TAC was used. For sVEP acuity, the amplitude response curve derived from time-locked cortical activity was used to extrapolate to zero response, giving an acuity estimate for each infant.
RESULTS: sVEP acuity was generally higher than TAC acuity. The rate of development was steeper for TAC than sVEP acuity with TAC starting at a much lower level. The ratio of sVEP to TAC acuity decreased exponentially with age reaching an asymptote of about 1.44 at 6 months.
CONCLUSIONS: Results were indistinguishable between centers suggesting that comparison of acuity measures obtained using variations of these methods across centers is possible.

Entities:  

Mesh:

Year:  1997        PMID: 9380367     DOI: 10.1097/00006324-199709000-00017

Source DB:  PubMed          Journal:  Optom Vis Sci        ISSN: 1040-5488            Impact factor:   1.973


  12 in total

1.  A new method of extrapolating the sweep pattern visual evoked potential acuity.

Authors:  Peng Zhou; Ming-Wei Zhao; Xiao-Xin Li; Xiao-Feng Hu; Xi Wu; Lan-Jun Niu; Wen-Zhen Yu; Xiu-Lan Xu
Journal:  Doc Ophthalmol       Date:  2007-10-31       Impact factor: 2.379

2.  Comparing enfant and PowerDiva sweep visual evoked potential (sVEP) acuity estimates.

Authors:  William H Ridder; Bradley S Waite; Timothy F Melton
Journal:  Doc Ophthalmol       Date:  2014-08-24       Impact factor: 2.379

3.  Methods of visual acuity determination with the spatial frequency sweep visual evoked potential.

Authors:  William H Ridder
Journal:  Doc Ophthalmol       Date:  2004-11       Impact factor: 2.379

4.  Similarities and differences between behavioral and electrophysiological visual acuity thresholds in healthy infants during the second half of the first year of life.

Authors:  Claudia Polevoy; Gina Muckle; Jean R Séguin; Emmanuel Ouellet; Dave Saint-Amour
Journal:  Doc Ophthalmol       Date:  2017-02-20       Impact factor: 2.379

5.  Effects of sweep VEP parameters on visual acuity and contrast thresholds in children and adults.

Authors:  Fahad M Almoqbel; Naveen K Yadav; Susan J Leat; Liseann M Head; Elizabeth L Irving
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-08-06       Impact factor: 3.117

6.  Curveball: A tool for rapid measurement of contrast sensitivity based on smooth eye movements.

Authors:  Scott W J Mooney; N Jeremy Hill; Melis S Tuzun; Nazia M Alam; Jason B Carmel; Glen T Prusky
Journal:  J Vis       Date:  2018-11-01       Impact factor: 2.240

7.  Meta-analysis of LCPUFA supplementation of infant formula and visual acuity.

Authors:  Ahmad Qawasmi; Angeli Landeros-Weisenberger; Michael H Bloch
Journal:  Pediatrics       Date:  2012-12-17       Impact factor: 7.124

Review 8.  VEP estimation of visual acuity: a systematic review.

Authors:  Ruth Hamilton; Michael Bach; Sven P Heinrich; Michael B Hoffmann; J Vernon Odom; Daphne L McCulloch; Dorothy A Thompson
Journal:  Doc Ophthalmol       Date:  2020-06-02       Impact factor: 2.379

9.  Threshold determination in sweep VEP and the effects of criterion.

Authors:  Naveen Kr Yadav; Fahad Almoqbel; Liseann Head; Elizabeth L Irving; Susan J Leat
Journal:  Doc Ophthalmol       Date:  2009-06-24       Impact factor: 2.379

10.  Searching for biomarkers of CDKL5 disorder: early-onset visual impairment in CDKL5 mutant mice.

Authors:  Raffaele Mazziotti; Leonardo Lupori; Giulia Sagona; Mariangela Gennaro; Grazia Della Sala; Elena Putignano; Tommaso Pizzorusso
Journal:  Hum Mol Genet       Date:  2017-06-15       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.